PYC.L
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union. It offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. The company also develops technology for use in the field of personalized medicine. Physiomics Plc was incorporated in 2001 and is based in Oxford, the United Kingdom.
Industry
Biotechnology
IPO Date
2004-12-20
Stock Exchange
LSE
Ticker
PYC.L
According to Physiomics Plc’s latest financial reports and current stock price. The company's current Enterprise Value is 342.26K. This represents a change of -63.61% compared to the average of 940.55K of the last 4 quarters.
The mean historical Enterprise Value of Physiomics Plc over the last ten years is 1.88M. The current 342.26K Enterprise Value has changed 1.72% with respect to the historical average. Over the past ten years (40 quarters), PYC.L's Enterprise Value was at its highest in in the December 2020 quarter at 5.97M. The Enterprise Value was at its lowest in in the December 2024 quarter at -253980.23.
Average
1.88M
Median
1.56M
Minimum
329.42K
Maximum
5.17M
Discovering the peaks and valleys of Physiomics Plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 479.86%
Maximum Annual Enterprise Value = 5.17M
Minimum Annual Increase = -75.25%
Minimum Annual Enterprise Value = 329.42K
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 646.21K | -55.04% |
| 2024 | 1.44M | 165.82% |
| 2023 | 540.65K | -75.25% |
| 2022 | 2.18M | -57.76% |
| 2021 | 5.17M | 26.91% |
| 2020 | 4.08M | 142.60% |
| 2019 | 1.68M | -12.05% |
| 2018 | 1.91M | 479.86% |
| 2017 | 329.42K | -59.94% |
| 2016 | 822.40K | -7.63% |
The current Enterprise Value of Physiomics Plc (PYC.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
874.68K
5-year avg
2.00M
10-year avg
1.88M
Physiomics Plc’s Enterprise Value is less than ValiRx plc (760.65K), greater than Trellus Health plc (-380286.07), greater than Polarean Imaging plc (-9106396.40), less than Roquefort Therapeutics plc (2.40M), less than Theracryf Plc (2.40M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 760.65K | N/A | |
| -380286.07 | N/A | |
| -9106396.40 | N/A | |
| 2.40M | N/A | |
| 2.40M | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Physiomics Plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Physiomics Plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Physiomics Plc's Enterprise Value?
What is the highest Enterprise Value for Physiomics Plc (PYC.L)?
What is the 3-year average Enterprise Value for Physiomics Plc (PYC.L)?
What is the 5-year average Enterprise Value for Physiomics Plc (PYC.L)?
How does the current Enterprise Value for Physiomics Plc (PYC.L) compare to its historical average?